Table 1 Demographic and clinical characteristics of included FTLD patients.
Diagnosis | bvFTD | SD | PNFA | CBD | PSP |
|---|---|---|---|---|---|
N | 41 | 5 | 6 | 16 | 29 |
Age, years | 66.8 ± 7.2 | 69.0 ± 9.0 | 61.3 ± 7.3 | 61.6 ± 7.7 | 72.7 ± 5.2 |
Gender, F% | 48.8 (20) | 80 (4) | 83.3 (5) | 50 (8) | 41.4 (12) |
FH* | 36.4 (12) | 0 (0) | 40 (2) | 18.3 (3) | 23.1 (6) |
Education, years | 7.1 ± 3.0 | 10.0 ± 3.7 | 6.8 ± 3.2 | 8.5 ± 4.8 | 7.2 ± 4.5 |
Age at onset, years | 63.7 ± 7.8 | 67.2 ± 9.1 | 56.6 ± 3.2 | 61.1 ± 5.4 | 70.5 ± 4.9 |
UPDRS-III | 9.2 ± 8.7 | 3.2 ± 3.1 | 6.1 ± 6.6 | 18.1 ± 10.9 | 22.7 ± 11.8 |
MMSE | 21.6 ± 5.8 | 21.0 ± 6.4 | 18.6 ± 6.8 | 22.6 ± 4.5 | 24.7 ± 4.0 |
NPI | 19.9 ± 14.1 | 12.0 ± 9.7 | 15.1 ± 10.5 | 8.0 ± 9.2 | 9.8 ± 9.8 |
FBI-A | 12.0 ± 7.7 | 11.8 ± 8.1 | 13.6 ± 8.9 | 8.0 ± 8.4 | 4.8 ± 6.5 |
FBI-B | 8.1 ± 6.7 | 4.8 ± 4.4 | 4.5 ± 5.3 | 1.6 ± 2.1 | 2.4 ± 3.9 |
FBI-AB | 21.8 ± 15.5 | 16.6 ± 10.7 | 19.0 ± 15.0 | 13.6 ± 8.6 | 7.3 ± 8.8 |
BADL | 0.7 ± 1.5 | 0.4 ± 0.8 | 0.0 ± 0.0 | 0.5 ± 0.9 | 0.8 ± 1.4 |
IADL | 2.3 ± 2.7 | 2.2 ± 2.6 | 1.6 ± 2.6 | 0.7 ± 1.5 | 1.3 ± 2.0 |